Esmolol in anesthesiology: Pharmacology and indications;Esmolol en anestesiologia: Farmacologia e indicaciones

Revista Espanola de Anestesiologia y Reanimacion

Volumn 46, Issue 9, 1999, Pages 404-414

  Fita, G ^a   Gomar, C ^a   Rovira, I ^a  

^a NONE

Author keywords

adrenergic receptor antagonists; Esmolol

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESMOLOL; LABETALOL; METOPROLOL; PINDOLOL; PROPRANOLOL; SOTALOL; TIMOLOL; PROPANOLAMINE DERIVATIVE;

ANESTHESIA; BLOOD PRESSURE MONITORING; BRADYCARDIA; DRUG CLEARANCE; DRUG METABOLISM; DRUG SELECTIVITY; DRUG STRUCTURE; ELECTROCARDIOGRAM; HEART RATE; HUMAN; HYPERTENSION; PATIENT MONITORING; REVIEW; TACHYCARDIA; DRUG EFFECT; HEMODYNAMICS;

ADRENERGIC BETA-ANTAGONISTS; HEMODYNAMIC PROCESSES; HUMANS; PROPANOLAMINES;

EID: 0033217427     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Brevibloc, colhidrato de esmolol. Monografía del producto. Madrid: Almirall Prodesfarma. IMC, 1999; 3-53.
2. Frishman WH, Silverman R. Clinical pharmacology of the new beta-adrenergic blocking drugs: comparative clinical experience and new therapeutic applications. Am Heart J 1979; 98: 119-131.
3. Lowenthal D, Porter S, Saris S, Bies C, Slegowski M, Staudacher A. Clinical pharmacology, pharmacodynamics and interactions with esmolol. Am J Cardiol 1985; 56: F14-F18.
4. Reynols RD, Gorczynski RJ, Quon CY. Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol 1986; 26 (Supl A): 3-A14.
5. Volz-Zang C, Eckrin B, Jahn P, Schneidowski B, Schulte B, Palm D. Esmolol, an ultrashort-acting, selective 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties. Eur J Clin Pharmacol 1994; 46: 399-404.
6. Quon CY, Stampfli HF. Biochemical properties of blood esmolol sterases. Drug Metab Disp 1985; 13: 420-424.
7. Quon CY, Mai K, Petil G, Stampfli HF. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Disp 1988; 16: 425-428.
8. Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinetic 1995; 28: 190-202.
9. Sum CY, Yacobi A, Kartzinel R, Stampfli HF, Davis CS. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther 1983; 34: 427-434.
10. Angaran DM, Schultz NJ, Tschida VH. Esmolol hydrochloride: an ultrashort-acting, beta adrenergic blocking agent. Clin Pharm 1986; 5: 288-303.
11. Benfield P, Sorkin EM Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetics properties, and therapeutic efficacy. Drugs 1987; 33: 392-412.
12. Voltz-Zang C, Eckrich B, Janh P, Schneidrowski B, Schulte B, Palm D. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptorantagonist: pharmacodynamic and pharmacokinetic properties. Eur J Clin Pharmacol 1994; 46: 399-404.
13. Reilly CS, Wood M, Koshakii RP, Wood AJ. Ultra-short-acting-blockade: a comparison with conventional beta-blockade. Clin Pharmacol Ther 1985; 38: 579-585.
14. Menkhaus PG, Reves JG, Kissin Y, Alvis JM, Govier AV, Samuelson PN et al. Cardiovascular effects of esmolol in anesthetized humans. Anesth Analg 1985; 64: 327-334.
15. Greenspan AM, Spielman SR, Horowitz LN, Senior S, Steck J, Laddu A. Electrophysiology of esmolol. Am J Cardiol 1985; 56: F19-F26.
16. Deegan R, Wood AJ. Beta-receptor antagonism does not fully explain esmolol-induced hypotension. Clin Pharmacol Ther 1994; 56: 223-228.
17. Jordan D, Shulman SM, Miller DE. Esmolol hydrochloride, sodium nitroprusside, and isoflurane differ in their ability to alter peripheral sympathetic responses. Anesth Analg 1993; 2: 281-290.
18. Askenazi J, MacCosbe PE, Hoff J, Turlapaty P, Hua TA, Laddu A. Hemodynamic effects of esmolol, an ultrashort-acting beta blocker. J Clin Pharmacol 1987; 27: 567-573.
19. Iskandrian AS, Hakki AH, Laddu A. Effects of esmolol on cardiac function: evaluation by noninvasive techniques. Am J Cardiol 1985; 56: F27-F32.
20. Ellenbogen KA, McCarthy EA, Pritchett EL. Effects of bolus injection of esmolol in healthy, exercising subjects. Clin Pharmacol Ther 1987; 41: 455-459.
21. Allin D, Anderson S, Angaran D, Brehm J. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline controlled safety and efficacy study in 160 patients. Am Heart J 1986; 112: 498-505.
22. Alexander R, Binns J, Hetreed M. A controlled trial of the effects of esmolol on cardiac function. Br J Anaesth 1994; 72: 594-595.
23. Ebert TJ, Berstein JS, Stowe DF, Roerig D, Kampine JP. Attenuation of hemodynamic responses to rapid sequence induction and intubation in healthy patients with a single bolus of esmolol. J Clin Anesth 1990; 2: 243-252.
24. Oxorn D, Knox JW, Hill J. Bolus doses of esmolol for the prevention of perioperative hypertension and tachycardia. Can J Anaesth 1990; 37: 206-209.
25. Parnass SM, Rothenberg DM, Kerchberger JP, Ivankovich AD. A single bolus dose of esmolol in the prevention of intubation-induced tachycardia and hypertension in an ambulatory surgery unit. J Clin Anesth 1990; 2: 232-237.
26. Singh H, Vichitveipaisal P, Gaines GY, White PF. Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. J Clin Anesth 1995; 7: 5-8.
27. Kindler CH, Schumacher PG, Schneider MC, Urwiler A. Effects of intravenous lidocaine and/or esmolol on hemodynamics responses to laryngoscopy and intubation: a double-blind, controlled clinical trial. J Clin Anesth 1996; 8: 491-496.
28. Miller DR, Martineau RJ, Wynands JE, Hill J. Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation. The Canadian Multicenter Trial. Can J Anaesth 1991; 38: 849-858.
29. Gaubatz CL, Wehner RJ. Evaluation of esmolol and fentanyl in controlling increases in heart rate and blood pressur during endotracheal intubation. AANA J 1991; 59: 91-96.
30. Korpinen R, Saarnivaara L, Siren K Sarna S. Modification of haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination. Can J Anaesth 1995; 42: 298-304.
31. Feng CK, Chan XH, Liu KN. A comparison of lidocaine, fentanyl and esmolol for attenuation of cardiovascular responses of laryngoscopy and tracheal intubation. Acta Anesth 1996; 34: 61-67.
32. Samaha T, Rasvussin P, Claquin C, Ecoffey C. Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine. Ann Fr Anesth Reanim 1996; 15: 36-40.
33. Sharma S, Mitra S, Grove Vk, Kalra R. Esmolol blunts the haemodynamic responses to tracheal intubation in treated hypertensive patients. Can J Anaesth 1996; 43: 778-782.
34. Gibson BE, Black S, Mass L, Cucchiara RF. Esmolol for the control of hypertension after neurologic surgery. Clin Pharmacol Ther 1988; 44: 650-653.
35. O'Dwyer JP, Yorukoglu D, Harris MN. The use of esmolol to attenuate the haemodynamic response when extubating patients following cardiac surgery-a double-blind controlled study. Eur Heart J 1993; 14: 701-704.
36. Gray RJ, Bateman TM, Czer LS, Conklin C, Matloff JM. Use of esmolol in hypertension after cardiac surgery. Am J Cardiol 1985; 56: F49-F56.
37. Fuhrman TM, Ewell CL, Pippin WD, Weaver JM. Comparison of the efficacy of esmolol and alfentanil to attenuate the hemodynamic responses to emergence and extubation. J Clin Anesth 1992; 4: 444-447.
38. Muzzi DA, Black S, Losasso TJ, Cuchiara RF. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg 1990; 70: 68-71.
39. Dyson A, Isaac PA, Pennant JH. Esmolol attenuates cardiovascular responses to extubation. Anesth Analg 1990; 71: 675-678.
40. Ayuso MA, Luis M, Sala X, Sánchez J, Traserra J. Effects of anesthesia technique on the hemodynamic response to microlaryngeal surgery. Ann Otol Rhinol Laryngol 1997; 106: 863-868.
41. Korpinen R, Simola M, Saarnivaara L. Effect of esmolol on the heart rate, arterial preassure and electrocardiographic changes during laryngomicroscopy. Acta Anesthesiol Scand 1997; 41: 371-375.
42. Korpinen R, Simola M, Saarnivaara L. Effect of esmolol on the hemodynamics and electrocardiographic changes during laryngomicroscopy under propofol-alfentanil anesthesia. Acta Anesthesiol Belg 1998; 49: 123-132.
43. Singh PP, Dimich Y, Samson Y, Sonnenklar N. A comparison of esmslol and labetalol for the treatment of perioperative hipertension in geriatric ambulatory surgical patients. Can J Anaesth 1992; 39: 559-562.
44. Van Den Berg AA. Use of esmolol to attenuate hemodynamic responses during cataract extraction. Middle East J Anesthesiol 1998; 14: 231-248.
45. Van Den Berg AA. Attenuation of haemodynamic responses to noxius stimuli in patients undergoing cataract surgery. A comparison of magnesium sulphate, esmolol, lignocaine, nitroglycerine and placebo given i.v. with induction of anaesthesia. Eur J Anaesthesiol 1997; 14: 134-137.
46. 2 pneumoperitoneum for laparoscopic surgery. Acta Anaesthesiol Scand 1998; 42: 510-517.
47. Newsome LR, Roth JV, Hug CC, Nagle D. Esmolol attenuates hemodynamic responses during fentanyl-pancuronium anaesthesia for aortocoronary bypass surgery. Anesth Analg 1986; 65: 451-456.
48. Reves JG, Crouhgwell ND, Hawkins E, Smith LR, Jacobs JR. Rankin S et al. Esmolol for a treatment of intraoperative tachycardia and/or hypertension in patients having cardiac operations. Bolus loading technique. J Thorac Cardiovasc Surg 1990; 100: 221-217.
49. Kling D, Boldt J, Zickmann B, Dapper F, Helpelmann C. The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol. Anaesthesist 1990; 39: 264-268.
50. Scheid H, Scheid CH. Cardiac surgery without the use of cardiopulmonary bypass: the challenges. Curr Opin Anaesth 1998; 11: 5-8.
51. Heres EK, Marquez J, Malkowski MJ, Magovern JA, Gravlee GP. Minimally invasive direct coronary artery bypass: anesthetic, monitoring and pain control considerations. J Cardiothorac Vase Anesth 1998; 12: 385-389.
52. Greenspun HG, Adourin UA, Fonger JD, Fan JS. Minimally invasive direct coronary artery bypass: surgical techniques and anesthesic considerations. J Cardiothorac Vasc Anesth 1996; 10: 507-509.
53. Abramson DC, Pivalizza EG, Gottschalk LI. Drug management for coronary revascularization without cardiac standstill: the use of high-dose of esmolol. J Cardiothorac Vasc Anesth 1995; 9: 184-188.
54. Pivalizza EG, Sweeny MS. High-dose esmolol and cardiopulmonary bypass for mitral valve replacement in beating heart. J Cardiothorac Vasc Anesth 1997; 11: 485-486.
55. Ti LK, Cheong KF, Chen FG. Esmolol resistance during anesthesia for thoracoscopically assisted coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1998; 12: 317-320.
56. Sacks EJ, Laddu AR. Esmolol to assess dynamic subpulmonary stenosis in a child after repair of complete transposition: a case report. Int J Clin Pharmacol Ther Toxicol 1989; 27: 117-119.
57. Nussbaun J, Zane EA, Thys DM. Esmolol for the treatment of hypercyanotic spells in infant with tetralogy of Fallot. J Cardiothorac Asnesth 1989; 3: 200-202.
58. Geary V, Thaker U, Chalmers P, Sheikn F. Esmolol in tetralogy of Fallot. J Cardiothorac Anesth 1989; 3: 524-526.
59. Thompson JP, West KJ, Hill AJ. The cardiovascular responses to double lumen endobronchial intubation and the effect of esmolol. Anaesthesia 1997; 52: 790-794.
60. Ryan T, Mannion D, O'Brien W, Grace P, Bouchier M, Haves D et al. Spinal cord perfusion pressure in dogs after control of proximal aortic hypertension during thoracic aortic cross-clamping with esmolol or sodium nitroprusside. Anesthesiology 1993; 78: 317-325.
61. Berendes E. Electroconvulsive therapy. Curr Opin Anaesth 1997; 10: 297-302.
62. Zvara DA, Brooker RE, McCall WV, Foreman AS, Murphy BA, Royster RL. The effect of esmolol on ST-segment depression and arrythmias after electroconvulsive therapy. Convuls Ther 1997; 13: 167-174.
63. Kolano JE, Chibber A, Calalang CC. Use of esmolol to control bleeding and heart rate during electroconvulsive therapy in a patient with an intracraneal aneurysm. J Clin Anaesth 1997; 9: 493-495.
64. Howie MB, Hiestand DC, Zvara DA, Kim PY, McSweeney TD, Coffman JA. Defining the dose range for esmolol used in electroconvulsive therapy. Anesth Analg 1992; 75: 805-810.
65. Kovac AL, Goto H, Pardo MP, Arakawa K. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy. Can J Anaesth 1991; 38: 204-209.
66. O'Flaherty D, Husain MM, Moore M, Wolff TR, Sills S, Giesecke AH. Circulatory responses during electroconvulsive therapy. The comparative effects of placebo, esmolol and nitroglycerin. Anaesthesia 1992; 47: 563-567.
67. Drop L, Castelli Y, Kaufmann M. Comparative doses and cost: esmolol versus labetalol during electroconvulsive therapy. Anesth Analg 1998; 86: 916-917.
68. Orstein E, Matteo RS, Weinstein JA, Schwartz AE. A controlled trial of esmolol for th induction of deliberate hypotension. J Clin Anesth 1988; 1: 31-35.
69. Pilli G, Gezeldemir ME, Bayhan N. Esmolol for hypotensive anesthesia in middle ear surgery. Acta Anesthesiol Belg 1996; 47: 85-91.
70. Boezaart AP, Van der Merwe J, Coetzee A. Comparison of sodium nitroprusside- and esmolol-induced controlled hypotension for functional endoscopy sinus surgery. Can J Anaesth 1995; 42: 373-376.
71. Blau WS, Kafer ER, Anderson JA. Esmolol is more effective than sodium nitroprusside in reducing blood loss during orthognathic surgery. Anesth Analg 1992; 75: 172-178.
72. Turlapaty P, Laddu A, Murphy VS, Singh B, Lee R. Esmolol: a tritable short-acting intravenous beta blocker for acute critical care settings. Am Heart J 1987; 114: 866-885.
73. Blanski L, Lutz J, Laddu A. Esmolol, the first ultra-short-acting intravenous beta blocker for use in critically ill patients. Heart Lung 1988; 17: 80-89.
74. Kirton OC, Windsor J, Wedderburn R, Gómez E, Shatz DV, Hudson J et al. Management of paroxysmal atrioventricular nodal reentrant tachycardia in the critically ill surgical patient. Crit Care Med 1997; 25: 761-766.
75. Kowey PR, Marinchak RA, Rials SI, Filart RA. Acute treatment of atrial fibrillation. Am J Cardiol 1998; 81: 16C-22C.
76. Plattia EV, Michelson EL, Portefield JK. Esmolol versus verapamil in the acute treatment of atrial fibrilation o flutter. Am J Cardiol 1989; 63: 925-929.
77. Tuman KJ, McCarthy RJ, Wong CA, Labarge AM, Spiess BD. Ivankovich AD. Comparative effects of esmolol and verapamil in a model of supraventricular tachydysrhythmia. Anesthesiology 1990; 73: 467-473.
78. Abrams J, Allen J, Allin D. Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrythmias: a multicenter double-blind clinical trial. Am Heart 1985; 110: 913-922.
79. The Esmolol Research Group. Intravenous esmolol for the treatment of supraventricular tachyarrhymia: results of a multicenter, baseline-controlled safety and efficacy in 160 patients. Am Heart 1986; 112: 498-505.
80. Barth C, Ojile M, Pearson AC, Labovitz AJ. Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina. Am Heart J 1991; 121: 782-788.
81. Sung RJ, Blanski L, Kirshenbaum J, MacCosbe P, Turlapaty P, Laddu AR. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrythmias and myocardial ischemia. J Clin Pharmacol 1986; 26 (Supl A): 15-26.
82. Ostman PL, Chesnut DH, Robillard JE, Weiner CP, Hernández MJ. Transplacental passage and hemodynamics effects of esmolol in the gravid ewe. Anesthesiology 1988; 69: 738-741.
83. Eisenach JC, Castro MI. Maternally administered esmolol produces fetal beta-adrenergic blockade and hypoxemia in sheep. Anesthesiology 1989; 71: 718-722.
84. Larson CP, Shuer LM, Cohen SE. Maternally administered esmolol decreases fetal as well as maternal heart rate. J Clin Anesth 1990; 2: 427-429.
85. Fivush B, Neu A, Furth S. Acute hypertension crises in children: emergencies and urgencies. Current Opin Pediatr 1997; 9: 233-236.
86. Trippel DL, Wiest DB, Gillette PC. Cardiovascular and antiarrhythmic effects of esmolol in children. J Pediatr 1991; 119: 142-147.
87. Wiest DB, Trippel DL, Gillette P, Garner SS. Pharmacokinetics of esmolol in children. Clin Pharmacol Ther 1991; 49: 618-623.
88. Knigthon JD, Crosse MM. Anaesthesic management of childhood thyrotoxicosis and the use of esmolol. Anesthesia 1997; 52: 67-70.
89. Wiest DB, Garner SS, Uber WE, Sade RM. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 1998; 115: 890-897.
90. Lowenthal DT, Porter RS, Achari R, Turlapaty P, Laddu AR, Matier WL. Esmolol-digoxin drug interaction 1987; 27: 561-566.
91. Johansen JW, Flaishon R, Sebel SP. Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. Anesthesiology 1997; 86: 364-371.
92. Johansen JW, Schneider G, Windsor AM, Sebel SP. Esmolol potentiates reduction of minimun alveolar isofluorane concentration by alfentanil. Anesth Analg 1998; 87: 671-676.
93. Kim KS, Kim KH, Shin WJ, Yoo HK. Neuromuscular interactions between mivacurium in rabbits. Anaesthesia 1998; 53: 140-145.
94. Lewis IH, Yousif D, Mullis SL, Homma S, Gabrielson GV, Jebara VA. Management of phaechromocytoma in two patients. J Cardiothorac Anesth 1994; 8: 223-230.
95. De Brujin NP, Reves JG, Crougwell N. Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy. Anesthesiology 1987; 66: 323-326.
96. Michelson EL, Portefield JK, Das G. A comparison of esmolol and verapamil in the treatment of atrial fibrillation/flutter. J Am Coll Cardiol 1986; 7: 157A-160A.
97. Gold MR, Dec GW, Cocca-Spofford D, Thompson BT. Esmolol and ventilatoy function in cardiac patients with COPD. Chest 1991; 100: 1.215-1.218.
98. Tobias JD, Sauder RA, Hirsman CA. Pulmonary reactivity to methacoline during beta-adrenergic blockade: propranolol versus esmolol. Anesthesiology 1990; 73: 132-136.
99. Sheppard D, DiStefano S, Byrd RC, Eschenbacher WI, Bell V, Stack J, Laddu A. Effects of esmolol on airway function in patients with asthma. J Clin Pharmacol 1986; 26: 169-174.
100. Buchi KN, Rollins DE, Tolman KG, Achari R, Drissel D, Hulse JD. Pharmacokinetics of esmolol in hepatic disease. J Clin Pharmacol 1987; 27: 880-884.